Please Wait
Applying Filters...
menu
    • menu
    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-20

    Virtual Booth

    Contact Supplier

    Menu

    Cyproterone Acetate

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,814Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    EMA committee recommends restriction in use of cyproterone
    EMA committee recommends restriction in use of cyproterone

    31 Mar 2020

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=122067&sid=2

    PHARMABIZ
    31 Mar 2020
    Share Share
    Restrictions in use of cyproterone due to meningioma risk
    Restrictions in use of cyproterone due to meningioma risk

    28 Mar 2020

    // EMA

    https://www.ema.europa.eu/en/news/restrictions-use-cyproterone-due-meningioma-risk-0

    EMA
    28 Mar 2020
    Share Share
    Restrictions in use of cyproterone due to meningioma risk
    Restrictions in use of cyproterone due to meningioma risk

    14 Feb 2020

    // EMA

    https://www.ema.europa.eu/en/news/restrictions-use-cyproterone-due-meningioma-risk

    EMA
    14 Feb 2020
    Share Share